The Chumakov Center is studying the possibility of three times injection the KoviVak vaccine to strengthen the immune response with low antibody levels, Interfax reports citing center director Aidar Ishmukhametov.
“In general, the absence of antibodies at one stage or another is not critical… Perhaps someone will need a third immunization depending on their health, age, comorbidities that can reduce the immune response. These issues are being worked out, “the agency quotes Ishmukhametov from an interview with Komsomolskaya Pravda radio station.
The specialist noted that the mode of antibody production may vary slightly among different people. “It is possible that in the future the approaches will be different,” said the director of the center.
At the end of March, the third, all-virion Russian vaccine against the KoviVak coronavirus of the Chumakov Center entered civil circulation. The head of the Ministry of Education and Science Valery Falkov on March 25 launched the production of the drug and personally launched the packaging of the first batch.
